Protein Expression for Novel Prognostic Markers (Cyclins D1, D2, D3, B1, B2, ITGβ7, FGFR3, PAX5) Correlate With Previously Reported Gene Expression Profile Patterns in Plasma Cell Myeloma-Reference-Cited by-同舟云学术

Protein Expression for Novel Prognostic Markers (Cyclins D1, D2, D3, B1, B2, ITGβ7, FGFR3, PAX5) Correlate With Previously Reported Gene Expression Profile Patterns in Plasma Cell Myeloma

Published:2015-05 Issue:5 Volume:23 Page:327-333
ISSN:1541-2016
Container-title:Applied Immunohistochemistry & Molecular Morphology
language:en
Short-container-title:

Author:

Mansoor Adnan,Akhter Ariz,Pournazari Payam,Mahe Etienne,Shariff Sami,Farooq Fahad,Elyamany Ghaleb,Shahbani-Rad Meer-Taher,Rashid-Kolvear Fariborz

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Medical Laboratory Technology,Histology,Pathology and Forensic Medicine

Reference32 articles.

1. . Review of 1027 patients with newly diagnosed multiple myeloma.;Kyle;Mayo Clin Proc,2003

2. Diagnostic criteria of multiple myeloma.;Kyle;Hematol Oncol Clin North Am,1992

3. Long-term survival in multiple myeloma.;Kyle;N Engl J Med,1983

4. . International staging system for multiple myeloma.;Greipp;J Clin Oncol,2005

5. . Treatment of multiple myeloma.;Barlogie;Blood,2004

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quantification of cyclin D1 and D2 proteins in multiple myeloma identifies different expression patterns from those revealed by gene expression profiling;Haematologica;2023-08-31

2. In-depth cytogenetic and immunohistochemical analysis in a real world cohort - reconsidering the role of primary and secondary aberrations in multiple myeloma;Haematologica;2023-08-16

3. Proteomic Profiling of Diffuse Large B-Cell Lymphomas;Pathobiology;2018

4. Mutational landscape reflects the biological continuum of plasma cell dyscrasias;Blood Cancer Journal;2017-02